BUY Gopal Snacks Limited — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)10 Aug 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Gopal Snacks Q2 Results: Net profit zooms nearly 2-fold on higher sales and exceptional gain
NewsCnbc-Tv18·2 Nov · 4d ago
Gopal Snacks reported Q2 FY27 revenue of Rs 461.5 crore, up 22.9% YoY, and PAT of Rs 45.9 crore, up 78.5% YoY. The company also commissioned a new Besan manufacturing unit in Nagpur.
NSE · Press Release·2 Nov · 4d ago
2 other SEBI-registered advisors have active long-term BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·3 Nov · 4d ago
Gopal Snacks Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
NSE · Outcome of Board Meeting·2 Nov · 4d ago
The Financial results for the quarter and half year ended 30.09.2026 and declaration of interim dividend, attached herewith.
BSE · Board Meeting·2 Nov · 4d ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·6 Nov · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Gopal Snacks
- BUY — HDFC Securities3 Nov 2026 · ~1 year · target ₹335 · Active
- BUY — Emkay Global3 Nov 2026 · ~1 year · target ₹375 · Active
- BUY — Motilal Oswal28 Jan 2026 · ~1 year · target ₹400 · Active
- BUY — Emkay Global21 Nov 2025 · ~1 year · target ₹500 · Active
- BUY — Ventura11 Nov 2024 · ~1 year · target ₹595 · Expired
More from Motilal Oswal
- BUY Zydus Lifesciences6 Nov 2026 · ~1 year · target ₹1,480 · Active
- BUY Neogen Chemicals6 Nov 2026 · ~1 year · target ₹2,765 · Active
- BUY BSE5 Nov 2026 · ~1 year · target ₹4,200 · Active
- BUY Apollo Hospitals Enterprise5 Nov 2026 · ~1 year · target ₹10,400 · Active
- BUY Bharat Electronics3 Nov 2026 · ~1 year · target ₹540 · Active

